Arcadia Biosciences, Inc. (RKDA)
NASDAQ: RKDA · Real-Time Price · USD
0.6981
-0.0052 (-0.74%)
Aug 6, 2026, 2:57 PM EDT - Market open
Arcadia Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Operating Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -9.32 | -2.34 | -7.04 | -13.99 | -15.61 | -16.13 |
Depreciation & Amortization | 0.05 | 0.15 | 0.77 | 0.98 | 1.36 | 2.32 |
Stock-Based Compensation | 0.17 | 0.23 | 0.51 | 0.72 | 1.11 | 1.54 |
Other Adjustments | 0.84 | -2.76 | -2.42 | 0.5 | -0.95 | -9.33 |
Change in Receivables | 0.36 | 0.17 | -0.76 | 0.18 | 0.59 | -0.04 |
Changes in Inventories | 0.45 | -0.31 | 0.55 | -2.42 | 1.12 | -2.38 |
Changes in Accounts Payable | -0.91 | -0.4 | -0.3 | -0.52 | -0.76 | -0.37 |
Changes in Unearned Revenue | - | - | - | - | - | -0.01 |
Changes in Other Operating Activities | 0.46 | 0.52 | -0.93 | -0.75 | -0.84 | -1.46 |
Operating Cash Flow | -4.25 | -4.74 | -9.63 | -15.29 | -13.98 | -25.87 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Investing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Capital Expenditures | - | - | -0.02 | -0.01 | -0.07 | -1.01 |
Sale of Property, Plant & Equipment | - | - | 0.33 | 0.12 | 0.92 | 0.02 |
Proceeds from Sale of Intangible Assets | 0.25 | 0.75 | 4 | - | - | - |
Purchases of Investments | - | - | - | -7.53 | - | - |
Proceeds from Sale of Investments | - | - | 5.02 | 2.5 | - | 21.85 |
Cash Acquisitions | - | - | - | - | - | -4.25 |
Proceeds from Business Divestments | - | - | - | 0.57 | 0.57 | - |
Other Investing Activities | 0.75 | - | -2 | - | - | - |
Investing Cash Flow | 0.25 | 0.75 | 7.34 | -4.34 | 1.42 | 16.61 |
Financing Activities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Long-Term Debt Repaid | - | - | - | - | - | -2.15 |
Net Long-Term Debt Issued (Repaid) | - | - | - | - | - | -2.15 |
Issuance of Common Stock | 2.08 | 0.01 | 0.01 | 6.01 | 5.01 | 25.21 |
Net Common Stock Issued (Repurchased) | 2.08 | 0.01 | 0.01 | 6.01 | 5.01 | 25.21 |
Other Financing Activities | -0.29 | - | - | -0.5 | -0.49 | -1.16 |
Financing Cash Flow | 1.8 | 0.01 | 0.01 | 5.51 | 4.52 | 21.9 |
Net Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Foreign Exchange Rate Adjustments | - | - | - | - | - | 0 |
Net Cash Flow | -2.21 | -3.98 | -2.28 | -14.13 | -8.04 | 12.64 |
Free Cash Flow
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Free Cash Flow | -4.25 | -4.74 | -9.64 | -15.3 | -14.05 | -26.88 |
Free Cash Flow Growth | - | - | - | - | - | - |
FCF Margin | -89.32% | -97.55% | -191.14% | -343.49% | -189.39% | -396.39% |
Free Cash Flow Per Share | -2.74 | -3.46 | -7.07 | -12.37 | -23.44 | -50.52 |
Levered Free Cash Flow | -9.28 | -2.38 | -6.97 | -16.69 | -14.56 | -19.72 |
Unlevered Free Cash Flow | -2.99 | -2.55 | -3.59 | -8.82 | -13.21 | -38.44 |